Pfizer Stock: Discounted Valuation Multiples?
I am neutral on Pfizer (PFE) as it has a strong competitive
position within the pharmaceutical and biotechnology industry,
strong growth momentum, and discounted valuation multiples relative
to the company’s trading history. On the other hand, the average
price target implies weak upside potential over the next year.
Pfizer is a Fortune 500 company headquartered in New York,
producing vaccines and medicines for cardiology, endocrinology,
immunology, oncology, and neurology. The company was established in
1849 by Charles Pfizer and Charles F. Erhart, with plants producing
fine chemicals. The company has its operations in several
countries, which enable it to benefit from economic surges even
when some markets may crash.
から 4 2022 まで 5 2022
から 5 2021 まで 5 2022